RecruitingPhase 2NCT06273072
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Sponsor
Johns Hopkins University
Enrollment
100 participants
Start Date
Dec 9, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This is a randomized clinical trial of metformin among overweight or obese adults with not well-controlled asthma despite maintenance inhaler therapy.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether metformin — a common diabetes medication — can improve asthma control in overweight and obese adults whose asthma is not well-controlled despite current treatment. Researchers believe metformin may reduce airway inflammation.
**You may be eligible if...**
- You are 18 or older
- You have a doctor-diagnosed asthma on regular maintenance treatment
- Your asthma is not well controlled (you score below 20 on the Asthma Control Test or had at least one flare requiring steroids in the past year)
- Your BMI is 25 kg/m² or higher (overweight or obese)
**You may NOT be eligible if...**
- You are pregnant or planning to become pregnant
- You have had a heart attack, stroke, or heart failure in the past 6 months
- You have other chronic lung diseases such as COPD or pulmonary fibrosis
- You are a current smoker or have a significant smoking history
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGMetformin hydrochloride extended-release tablets
titrated to 2000 mg once daily
DRUGVisually identical placebo Metformin hydrochloride extended-release tablets
placebo
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06273072
Related Trials
ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia
NCT073996659 locations
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
NCT06307665135 locations
Personalized Environment and Genes Study
NCT003412371 location
PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults
NCT069811693 locations
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
NCT06023589143 locations